Phase I Study of ALT-801 in Patients With Progressive Metastatic Malignancies.
Phase of Trial: Phase I/II
Latest Information Update: 30 Aug 2017
At a glance
- Drugs ALT 801 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 03 Nov 2009 Planned number of patients changed from 46 to 26 as reported by ClinicalTrials.gov.
- 03 Nov 2009 Actual end date (Oct 2009) added as reported by ClinicalTrials.gov.